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A strain of yeast, Hansenula mrakii, secretes a toxin that kills sensitive yeasts, such as Saccharomyces cere- 
visiae. Monoclonal antibodies raised against the toxin had both binding and neutralizing activities. The 
toxin in culture media was isolated by an affinity column of monoclonal antibody. The toxin is a basic poly- 
peptide with an isoelectric point at pH 9.1, and devoid of mannosides. It is composed of 88 amino acid 
residues with a molecular size of 10 721 Da. The monoclonal antibodies could be applicable to the analysis 
of biologically active sites on the toxin, in an attempt to synthesize chemically a small peptide with killer 
activity and little immunogenicity. 
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1. INTRODUCTION 
Some yeast strains secrete into culture media the 
factors, designated killer toxins, which kill sen- 
sitive strains of yeast [l]. Recently, Ashida et al. 
[2] described another killer toxin that was pro- 
duced by Hansenula mrakii. The toxin of 
H. mrakii is stable against heat and unaffected 
over a wide range of pH changes, contrasting with 
most of the killer toxins [3-51. 
We raised monoclonal antibodies against the 
toxin secreted by H. mrakii, and applied them to 
its isolation and characterization. 
2. MATERIALS AND METHODS 
2.1. Preparation of killer toxin 
The killer strain of H. mrakii (IF0 0895 
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[LKB169]), obtained from Institute for Fermenta- 
tion, Osaka, Japan, was cultured at 30°C for 1 day 
in minimal medium. The toxin in culture medium, 
detectable by bioassay with the sensitive strain 
(Saccharomyces cerevisiae, diploid, no. 5059 from 
our stock culture) [6], was isolated by gel filtration 
in Sephadex G-50 (fig.1). 
2.2. Monoclonal antibodies 
A female BALB/c mouse received intra- 
cutaneously 125 ,ug killer toxin emulsified in 
Freund’s complete adjuvant. After 1 month, the 
mouse was injected with 50 pg toxin intravenously. 
Hybridization, subsequent culture and cloning 
were carried out by a modification [7] of the 
method of K(ihler and Milstein [8]. Antibodies 
were screened by enzyme immunoassay that sand- 
wiched them between the toxin fixed on a solid- 
phase support and rabbit anti-mouse y-globulin 
antibody labeled with horseradish peroxidase 
(details in [9]). The neutralizing activity was tested 
by the method given in the legend to fig.2. 
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Fig.1. Isolation of the killer toxin in culture media of 
H. mrakii by gel filtration in Sephadex G-50. Fractions 
were monitored for the activity to kill S. cerevisiae (0) 
and the absorbance at280 nm (0). ’ 
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Fig.2. Neutralization of killer toxin with monoclonal an- 
tibody. A varying amount of toxin in 25 gl YPAD 
medium was mixed with an equal volume of medium 
containing monoclonal antibody and incubated at 37°C 
for 1 h in wells of a polyvinyl microtiter plate. The mix- 
ture was then tested for the activity to kill S. cerevisiae 
(2000 cells in 50 ~1 medium). Lanes: 1, 2, 11, toxin-free 
medium; 3-10, 10, 5, 2.5, 1, 0.5, 0.25, 0.1 and 
0.05 pg/ml of killer toxin, respectively. Row a received 
250/cg/ml monoclonal antibody to hepatitis B surface 
antigen (negative antibody control). Rows b, c and d 
received monoclonal antibody against killer toxin (no. 
6207) at 250, 25 and 2.5 pg/ml, respectively. Rows e, f 
and g received the other monoclonal antibody against 
killer toxin (no. 6217) at 250, 25 and 2.5 pg/ml, respec- 
tively. 
2.3. Affinity chromatography 
Monoclonal antibody against killer toxin 
(monoclonal no. 6207, see section 3) was coupled 
to Sepharose 4B by means of CNBr [lo]. 
2.4. Characterization of killer toxin 
Electrophoresis in a polyacrylamide gel slab in 
the presence of SDS was performed as in [ll]. 
Polypeptides in the gel slab were transferred onto 
a nitrocellulose sheet (Millipore, Bedford, MA), 
and the toxin detected by incubation with mono- 
clonal antibody and then with goat anti-mouse y- 
globulin antibody labeled with horseradish perox- 
idase using the immunoblot system (Bio-Rad, 
Richmond, CA). Isoelectrofocusing was carried 
out in 5% polyacrylamide gel containing 0.5% 
Ampholine [ 121. 
2.5. Biochemical analyses 
A preparation of killer toxin (20 pg), purified by 
affinity chromatography, was hydrolysed and ap- 
plied to a Hitachi high-speed amino acid analyser 
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Fig.3. Purification of killer toxin (0) by affinity column 
of monoclonal antibody. After application of cell-free 
medium from the culture of H. mrakii, the column was 
eluted with glycine-HCl buffer (0.2 M, pH 2.2). 
254 
Volume 195, number 1,2 FEBS LETTERS January 1986 
(model 835, Hitachi, Tokyo). The content of tryp- 
tophan was determined spectrophotometrically 
[13]. Protein was determined by the method of 
Lowry et al. [14], employing bovine serum 
albumin as the standard. Mannosides were deter- 
mined by the capacity to bind with jackbean con- 
canavalin A (Miles, Elkhart, IN) according to 
Wood and Sarinana [ 151. 
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25.7- 
2.6. Amino acid sequence 
s 
0 
5 12.3- 
Purified killer toxin (500 pg) was dissolved in 
500~1 Tris-HCl buffer (0.13 M, pH 7.6) contain- 
ing 6 M guanidine hydrochloride and 10 mM di- 
thiothreitol and incubated at 37°C overnight. The 
reduced toxin was digested with trypsin (Wor- 
thington, Freehold, NJ), chymotrypsin (Wor- 
thington), Staphylococcus aureus V8 protease 
(Sigma, St. Louis, MO) or lysyl endopeptidase 
(Wako, Osaka), added at a weight ratio of 1: 100. 
Amino acid sequences of the obtained peptides 
were determined by an automatic Edman 470A 
protein sequencer (Applied Biosystems, Foster, 
CA). 
2 6.2- 
3.0- 
Fig.4. Electrophoresis of purified killer toxin. A strip of 
gel was stained for protein with Coomassie brilliant blue 
(lane A). Another strip was transferred onto a nitro- 
cellulose sheet and immunoblotted for the toxin (lane B). 
3. RESULTS 
3.1. Monoclonal antibodies : 30 Ill 
Antibody to killer toxin was detected by enzyme 
immunoassay in 2 out of 400 wells containing 
hybridoma cells. They were designated as mono- 
clonal nos 6207 and 6217. Hybridoma cells were 
propagated in the peritoneal cavity of mice made 
ascitic by the injection with 2,6,10,16tetramethyl- 
pentadecane. Antibodies in ascites fluid were 
precipitated with 2 M (NH&S04, and purified by 
gel filtration on Sephadex G-200 (Pharmacia, 
Uppsala). Both monoclonal antibodies neutralized 
the killing activity of toxin (fig.2). 
3.2. Purification of killer toxin by affinity 
chromatography 
The killer toxin in cell-free concentrate of media 
from the culture of N. mrakii was purified by the 
affinity column of monoclonal antibody to killer 
toxin (fig.3). 
Fig.5. Isoelectrofocusing of purified killer toxin. After 
elektrofocusing, el slices were eluted with distilled 
water and tested for the activity to kill S. cerevisiue (0) 
and pH (0). 
3.3. Physicochemical characters of killer toxin 
When a preparation of killer toxin, purified by 
The toxin had an isoelectric point at pH 9.1, 
affinity chromatography, was subjected to electro- 
thereby indicating its basic nature (fig.5). It did not 
phoresis, it was detected as a single band (fig.4). 
bind with concanavalin A, indicating the lack of 
mannosides. 
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3.4. Amino acid sequence of killer toxin 
The complete amino acid sequence of killer tox- 
in is given in fig.6. It is composed of 88 amino acid 
residues with a calculated molecular size of 
10 721 Da. The amino acid composition of the tox- 
in estimated by amino acid analysis was very close 
to that determined from the sequence (table 1). 
4. DISCUSSION 
By means of a monoclonal antibody, the killer 
toxin secreted by H. mrakii was purified and 
characterized. The toxin is a basic protein with an 
isoelectric point at pH 9.1, and is composed of 88 
amino acid residues with a molecular size of 
10721 Da. It is devoid of mannosides. 
The toxin secreted by H. mrakii is smaller than 
Kr killer toxin (18.5 kDa) [la] or the toxin from 
Pichia kluyveri (19 kDa) [5] and larger than that 
from Hansenula saturnus (8.5 kDa) [17]; it com- 
pares in size with the toxin from Kluyveromyces 
lactis (10 kDa) [4]. It is basic in nature unlike most 
of the reported toxins that are acidic proteins 
[5,17,18]. 
Yeasts harboring the plasmid containing recom- 
binant complementally DNA have been applied to 
the synthesis of a number of biologically active 
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Fig.6. Amino acid sequence of the killer toxin from Hansenura mrakii. Tryptic peptides (T), chymotryptic peptides (C), 
peptides obtained by digestion with Staphylococcus aureus V8 protease (S) and peptides obtained by digestion with lysyl 
endopeptidase (L), subjected to Edman degradation, are shown, The sequence from the 1st to 30th position was con- 
firmed by Edman degradation of undigested toxin. 
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Table 1 ACKNOWLEDGEMENTS 
Amino acid composition of the killer toxin of H, mrakii 
Amino acid Residues per polypeptide 
Analysisa Sequenceb 
Aspartic acid 11 12 
Threonine 8 9 
Serine 5 5 
Glutamic acid 4 4 
Proline 2 2 
Glycine 13 13 
Alanine 4 3 
Valine 5 5 
Methionine 3 3 
Isoleucine 5 5 
Leucine 1 1 
Tyrosine 3 3 
Phenylalanine 1 1 
Lysine 3 3 
Histidine 1 1 
Arginine 4 4 
Tryptophan 3 4 
Cysteine 9 10 
Total residues 85 88 
a The number of glycine was estimated at 13 to make a 
polypeptide with a molecular size estimated from the 
sequence analysis. The other amino acids were 
calculated pro rata and the nearest moles were 
adopted. 
The authors thank Professor Tatsuo Ishikawa, 
Institute of Applied Microbiology, University of 
Tokyo, as well as Drs Kozo Ouchi, Takamichi 
Nishiya and Takeaki Ishikawa, for their valuable 
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